USE OF AN IMPEDED ANDROGEN-DANAZOL-IN MANAGEMENT OF BENIGN BREAST DISORDERS

被引：70

作者：

ASCH, RH ^{[1
]}

GREENBLATT, RB ^{[1
]}

机构：

[1] MED COLL GEORGIA,DEPT ENDOCRINOL,AUGUSTA,GA 30902

来源：

关键词：

D O I：

10.1016/S0002-9378(16)33237-9

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：130 / 134

页数：5

共 12 条

[1] ENOVID THERAPY (NORETHYNODREL WITH MESTRANOL) FOR FIBROCYSTIC DISEASE
ARIEL, IM
[J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1973, 117 (04) : 453 - 459
[2] DICZFALUSY E, 1961, OESTROGENE BEIM MENS
[3] FECHNER RE, 1972, CANCER, V29, P566, DOI 10.1002/1097-0142(197203)29:3<566::AID-CNCR2820290306>3.0.CO
[4] 2-9
[5] GREENBLATT RB, 1971, FERTIL STERIL, V22, P102
[6] HILF R, 1973, CANCER RES, V33, P2054
[7] LEIS HP, 1970, DIAGNOSIS TREATMENT
[8] BIOLOGICAL BASIS FOR MANAGEMENT OF BENIGN DISEASE OF BREAST - CASE AGAINST SUBCUTANEOUS MASTECTOMY
PEACOCK, EE
[J]. PLASTIC AND RECONSTRUCTIVE SURGERY, 1975, 55 (01) : 14 - 20
[9] RECLUS P, 1883, REV CHIR, V3, P761
[10] Taylor HC, 1936, SURG GYNECOL OBSTET, V62, P562